Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coloflor
- Development stage
- Unknown
- Lead developer
- OLEOFARM
- Modality
- Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Coloflor is a brand of probiotic dietary supplements developed and manufactured by the Polish company OLEOFARM. The product line is designed to support and restore healthy intestinal microbiota for different age groups and needs. [9] The products contain various strains of live bacteria. - **Coloflor Baby** is formulated for newborns and infants and contains the probiotic strain *Lactobacillus rhamnosus GG* (ATCC 53103) in an MCT oil suspension, administered as drops. [1, 6] - **Coloflor Max** is intended for children over 6 years old and adults, providing a higher dose of microencapsulated *Lactobacillus rhamnosus GG* (ATCC 53103) along with the prebiotic inulin in a capsule form. [3] - **Coloflor Cesario** is specifically designed for newborns and infants born via cesarean section and contains a combination of three bacterial strains: *Lactobacillus rhamnosus GG* (ATCC 53103), *Lactobacillus fermentum* (CECT5716) Hereditum®, and *Bifidobacterium infantis* M-63. [2, 5, 11]
- Brand names
- ColoflorColoflor BabyColoflor MaxColoflor Cesario
- Other names
- Coloflor (probiotic)
Beyond the preview
Go deeper on Coloflor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coloflor.